Beam Therapeutics BEAM is developing its lead pipeline candidate, BEAM-101, a base-editing therapy, in the phase I/II BEACON study for treating sickle cell disease (SCD), an inherited blood disorder.

"Chemical rockets that we use today, even with the extra speed boost from flying by planets, or from swinging by the sun for ...

Beam Global (BEEM) has been granted another new patent by the USPTO. The patent covers Beam Global’s Phase Change Composite spacer product for ...

Conspiracy theories: love them or hate them, they aren't going anywhere soon. For a conspiracy theory to have real staying power, it needs both a compelling narrative, and an audience who is either ...

Optical phased arrays (OPAs) and beam steering technologies are at the forefront of advancements in optical systems, particularly in applications like LiDAR (Light Detection and Ranging).

Israel’s experimental air-defense system known as the Iron Beam uses laser technology to strike down drones and rockets, but military analysts say the device needs U.S. support to improve its ...

This Beam Global Press Release may contain forward-looking statements. All statements in this Press Release other than statements of historical facts are forward-looking statements. Forward ...

SAN DIEGO, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM), a leading provider of innovative and sustainable infrastructure solutions for the electrification of transportation and energy ...

This platform gives TSMC the opportunity to take the next step forward in exploring multiple e-beam technology as a lithography option at 22 nanometer and more advanced process nodes. Multiple e-beam ...

More information: Chen Cui et al, Vlasov simulations of electric propulsion beam, Plasma Sources Science and Technology (2024). DOI: 10.1088/1361-6595/ad98c0 ...

The patent covers Beam Global’s Phase Change Composite ... runaway propagation in Li-ion battery packs. The PCC™ spacer technology is designed to facilitate automated, high-volume battery ...